Rover Reports Third Quarter 2022 Financial Results
Rover Group, Inc. (NASDAQ: ROVR) reported significant financial growth for Q3 2022, with revenue increasing 45% year-over-year to $50.9 million. The gross booking value reached $213.7 million, up 36%. Total bookings grew 18% to 1.5 million. The company experienced a net loss of $15.5 million, an improvement from a loss of $84.5 million in Q3 2021. Looking forward, Rover raised its revenue guidance for 2022 to a range of $171 - $173 million, reflecting confidence despite potential macroeconomic challenges.
- Revenue increased 45% to $50.9 million.
- Gross booking value up 36% to $213.7 million.
- Total bookings rose 18% to 1.5 million.
- GAAP net loss reduced to $15.5 million from $84.5 million.
- Despite revenue growth, the company continues to experience a net loss.
- Full year impacts from Omicron and elevated cancellation rates remain uncertain.
- Revenue increased to
$50.9 million , up45% year-over-year - Gross booking value of
$213.7 million , up36% year-over-year - Total bookings of 1.5 million, up
18% year-over-year
SEATTLE, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Rover Group, Inc. (“Rover” or the “Company”) (NASDAQ: ROVR), the world’s largest online marketplace for pet care, today announced financial results for the quarter ended September 30, 2022.
"We reported a strong third quarter, with revenue growth of
Third Quarter 2022 Highlights:
- Revenue increased
45% to$50.9 million , compared to$35.2 million in Q3 2021. - GBV grew
36% to$213.7 million , compared to$157.1 million in Q3 2021. - Total Bookings increased
18% to 1.5 million, compared to 1.3 million in Q3 2021. New bookings increased3% to 267,000, compared to 259,000. Repeat bookings increased22% to 1.2 million, compared to 1.0 million. - GAAP net loss and net loss margin was
$15.5 million and30% , compared to a GAAP net loss and net loss margin of$84.5 million and239% in Q3 2021. - Adjusted EBITDA and Adjusted EBITDA margin was
$10.2 million and20% , compared to$6.6 million and19% in Q3 2021.
Fourth Quarter and Updated Full Year 2022 Guidance
Fourth Quarter 2022
- Revenue
- Rover anticipates revenue in the range of
$49 -$51 million .
- Rover anticipates revenue in the range of
- Adjusted EBITDA
- Rover anticipates Adjusted EBITDA in the range of
$6 -$8 million .
- Rover anticipates Adjusted EBITDA in the range of
Full Year 2022
- Revenue
- Rover anticipates revenue in the range of
$171 -$173 million , a year-over-year increase of57% at the midpoint of the projected range.
- Rover anticipates revenue in the range of
- Adjusted EBITDA
- Rover anticipates Adjusted EBITDA in the range of
$16 -$18 million .
- Rover anticipates Adjusted EBITDA in the range of
Both the low and high ends of revenue guidance continue to assume the full year impact related to Omicron and the recent macroeconomic headwinds, inclusive of elevated cancellation rates. The high end of guidance assumes cancellation rates remain steady from September, though seasonally adjusted for the remainder of the year, while the low end assumes higher cancellation rates and lower booking demand.
The change in the Adjusted EBITDA guidance reflects the increase in revenue guidance and anticipated continued ramp in marketing investment.
Subsequent events
As disclosed in a Form 8-K filed on October 21, 2022, Rover entered into a binding settlement term sheet with the named plaintiff in the case captioned Melanie Sportsman v. A Place for Rover, Inc. The term sheet provides that Rover will make a total payment of
About Rover
Founded in 2011 and based in Seattle, Rover (Nasdaq: ROVR) is the world’s largest online marketplace for pet care. Rover connects pet parents with pet providers who offer overnight services, including boarding and in-home pet sitting, as well as daytime services, including doggy daycare, dog walking, and drop-in visits. To learn more about Rover, please visit https://www.rover.com.
Conference Call and Webcast Information
Rover will host a conference call today at 1:30 p.m. PT (4:30 p.m. ET) to discuss its third quarter 2022 financial results and provide commentary on business performance. The conference call may be accessed by registering at the following link: https://register.vevent.com/register/BId0ada358ebbf49919863e9961a33825a. Once registered, you will be provided with a dial-in and conference ID. This call will contain forward- looking statements and other material information regarding Rover’s financial and operating results.
The live webcast and this earnings press release can be accessed from Rover’s investor relations website at https://investors.rover.com/, along with an Investor Presentation and Non-GAAP Reconciliation Supplement posted under the “News & Events-Presentations” section of the same website. A webcast replay will be available at the same website address shortly after the conclusion of the live event and will be accessible for at least 90 days.
Available Information
Rover announces material information to the public about the Company, its products and services and other matters through a variety of means, including filings with the SEC, press releases, public conference calls, webcasts, its website (www.rover.com), and its investor relations website (https://investors.rover.com). Rover uses these channels, as well as social media, including its Twitter account (@RoverDotCom), its LinkedIn account (https://www.linkedin.com/company/roverdotcom/), and its YouTube page (https://www.youtube.com/channel/UCAPW_dKc5hmvDEl8oYnJfdA), to communicate with investors and the public news and developments about Rover and other matters and in order to achieve broad, non-exclusionary distribution of information to the public and for complying with its disclosure obligations under Regulation FD. Rover encourages investors, the media, and others interested in the Company to review the information it makes public in these locations, as such information could be deemed to be material information.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, which involve substantial risks and uncertainties. These forward-looking statements include, but are not limited to, Rover’s expectations or predictions of future financial or business performance or conditions, including guidance and projections for the fourth quarter of 2022 and full year 2022, brand, market share, future growth and expansion opportunities, LTV trends, customer acquisition goals, settlement of the Melanie Sportsman v. A Place for Rover, Inc. case, potential changes to Rover's platform, and COVID recovery and macroeconomic trends. Forward-looking statements include all statements that are not historical facts and can be identified by terms such as "believe," "may," "will," "continue," "anticipate," "assume," or similar expressions and the negatives of those terms. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance.
The potential risks and uncertainties that could cause actual results to differ from the results predicted include, among others, including developments in the COVID-19 pandemic and general macroeconomic and geopolitical conditions and the resulting impact on our business and operations, our ability to retain existing and acquire new pet parents and pet care providers, the success of our marketing strategies and investments, competition, investments in new products or offerings, our brand and reputation, and other legal and regulatory developments, including those relating to or resulting from the Sportsman case. For additional information on other potential risks and uncertainties that could cause actual results to differ from the results predicted, please see those risks and uncertainties included under the caption "Risk Factors" and elsewhere in our annual report on Form 10-K and quarterly reports on Form 10-Q filed with the U.S. Securities and Exchange Commission. Additional factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements can be found in Rover’s other filings with the SEC which are available, free of charge, on the SEC’s website at www.sec.gov and available on the investor relations page of Rover’s website. Investors are cautioned not to place undue reliance on the forward-looking statements. All information provided in this release and in the attachments is as of the date hereof and is based on then-current expectations, estimates, forecasts, and projections and the beliefs and assumptions of management. We undertake no duty to update this information unless required by law.
The information that can be accessed through hyperlinks or website addresses included herein is deemed not to be incorporated in or part of this press release.
Definitions
- A booking is defined as a single arrangement between a pet parent and pet care provider, which can be for a single night or multiple nights for overnight services, or for a single walk/day/drop-in or multiple walks/days/drop-ins for daytime services. New bookings is defined as the total number of first-time bookings that new users, which Rover refers to as pet parents, book on our platform in a period. Repeat bookings are defined as the total number of bookings from pet parents who have ever had a previous booking on Rover, inclusive of pet parents who had their first booking within the same quarter.
- Gross Booking Value, or GBV, represents the dollar value of bookings on our platform during a period, prior to cancellations, and is inclusive of pet care provider earnings, service fees, add-ons, taxes, and alterations, and is exclusive of tips and Rover's other ancillary revenue streams.
Non-GAAP Financial Measures
To supplement our condensed consolidated financial statements prepared and presented in accordance with U.S. generally accepted accounting principles, or GAAP, we use non-GAAP financial measures in this earnings release and/or our related earnings call, including Adjusted EBITDA, Adjusted EBITDA margin, Contribution, Contribution margin, and Non-GAAP operating expenses (collectively, the “Non-GAAP Financial Measures”), each as defined below. We provide a reconciliation of the historical Non-GAAP Financial Measures to their most directly comparable historical GAAP financial measures in tabular form below. The Non-GAAP Financial Measures are supplemental measures of our performance that are neither required by, nor presented in accordance with, GAAP. The Non-GAAP Financial Measures have limitations as an analytical tool, which limitations are described below, and you should not consider them in isolation, or as a substitute for, GAAP financial measures.
We use the Non-GAAP Financial Measures to evaluate the health of our business, measure our operating performance, identify trends, prepare financial forecasts and make strategic decisions, including those related to operating expenses, and as a means to evaluate period-to-period comparisons. We consider the Non-GAAP Financial Measures to be important measures because they help illustrate underlying trends in our business and our historical operating performance on a more consistent basis.
We believe that these Non-GAAP Financial Measures, when taken together with their corresponding comparable U.S. GAAP financial measure, provide meaningful supplemental information to investors as they provide a basis for period-to-period comparisons of our business by excluding the effect of certain non-cash and cash gains, expenses, losses and variable charges that may not be indicative of our recurring core business, results of operations, or outlook. We believe these Non-GAAP Financial Measures are useful to investors because they (1) they allow for greater transparency with respect to key metrics used by management in its financial, operational and strategic decision-making and in assessing the health of our business and our operating performance, (2) are used by our institutional investors and the analyst community to help them analyze the health of our business, (3) allow investors and others to understand and evaluate our operating results in the same manner as our management and board of directors, and (4) provide a reasonable basis for comparing our ongoing results of operations and those of other companies.
Examples of the limitations of the Non-GAAP Financial Measures include:
- Adjusted EBITDA excludes certain recurring, non-cash charges, such as depreciation of property and equipment and amortization of intangible assets, and although these are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
- Adjusted EBITDA excludes certain restructuring and acquisition and merger-related charges, some or all of which may be settled in cash;
- Adjusted EBITDA and non-GAAP operating expenses exclude stock-based compensation expense, which has been, and will continue to be for the foreseeable future, a significant recurring expense in our business as we grow as a company and an important part of our compensation strategy;
- Adjusted EBITDA does not reflect the components of other income (expense), net, which consists primarily of realized and unrealized gains and losses on foreign currency transactions, realized gains and losses from the change in fair value of investments and financial instruments and sales of such investment, and our share of income or loss from our investment in an early-stage service for pet parents that is complementary to our current offerings;
- Adjusted EBITDA does not reflect period-to-period changes in taxes, income tax expense or the cash necessary to pay income taxes;
- Adjusted EBITDA and non-GAAP general and administrative expense exclude certain legal settlements that may reduce cash available to us;
- these measures exclude significant expenses and income that are required by GAAP to be recorded in our financial statements;
- these measures are subject to inherent limitations as they reflect the exercise of judgments by management about which expense and income are excluded or included in determining these Non-GAAP Financial Measures; and
- our calculation of these Non-GAAP Financial Measures may differ from similarly titled non-GAAP measures, if any, reported by our peer companies, or our peer companies may use other measures to calculate their financial performance, and therefore our use of the Non-GAAP Financial Measures may not be directly comparable to similarly titled measures of other companies.
To compensate for these limitations, management presents the Non-GAAP Financial Measures in connection with GAAP results. We encourage investors and others to review our financial information in its entirety, not to rely on any single financial measure, and to view the Non-GAAP Financial Measures in conjunction with their respective related GAAP financial measures. In addition, such financial information is unaudited and does not conform to SEC Regulation S-X and as a result such information may be presented differently in our future earnings releases and filings with the SEC.
The Non-GAAP Financial Measures are not indicative of our overall results, an indicator of past or future financial performance, a financial measure of total company profitability, and are not intended to be used as a proxy for total company profitability nor imply profitability for our business. Also, in the future we may incur expenses or charges such as those being adjusted in the calculation of these Non-GAAP Financial Measures. Our presentation of these Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items.
We define Adjusted EBITDA as net loss excluding depreciation and amortization, stock-based compensation expense, interest expense, interest income, change in fair value, net, other income (expense), net, income tax expense or benefit, and non-routine items such as investment impairment, restructuring costs, certain acquisition and merger-related costs and transaction-related expenses, and certain legal settlements. Adjusted EBITDA margin as presented in the reconciliation table below is Adjusted EBITDA for a period divided by revenue for the same period.
We define Contribution as revenue less cost of revenue (exclusive of depreciation and amortization shown separately), adjusted to exclude amortization of internally developed software from cost of revenue (exclusive of depreciation and amortization shown separately). Contribution margin is calculated by dividing Contribution for a period by revenue for the same period.
Operating expenses are defined as operations and support expense, marketing expense, product and development expense, and general and administrative expense. We define Non-GAAP operating expenses as operating expenses excluding the non-cash expenses arising from the grant of stock-based awards, and in the case of non-GAAP general and administrative expense, excluding certain legal settlements. These non-GAAP operating expenses are also presented as a percentage of revenue, which is calculated by dividing the specific non-GAAP operating expense for a period by revenue for the same period.
Beginning with the periods covered by this release, we have redefined Adjusted EBITDA and Non-GAAP general and administrative expense to omit the impact of certain legal settlements, including the accrual for the binding settlement term sheet referred to in the section titled “—Subsequent events.” Legal settlement amounts were immaterial during the three and nine months ended September 30, 2021. We believe the adjustments described above are useful to investors by enabling them to better assess our operating performance in the context of current period results and provide for better comparability with our historically disclosed Adjusted EBITDA and non-GAAP general and administrative expense amounts.
Our fourth quarter 2022 and full year 2022 guidance also includes Adjusted EBITDA. Due to the forward-looking nature of these projections, specific quantification of the amounts that would be required to reconcile such projections to GAAP measures cannot be reasonably calculated or predicted at this time without unreasonable efforts and Rover’s management believes that it is not feasible to provide accurate forecasted non-GAAP reconciliations. For example, the non-GAAP adjustment for stock-based compensation expense requires additional inputs such as number of shares granted and market price that are not currently ascertainable.
ROVER GROUP, INC.
Key Business Metrics
(Bookings and users in thousands, GBV dollars in millions, ABV and per-user metrics in units)
(unaudited)
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||
Bookings | |||||||||||||||
New Bookings | 267 | 259 | 706 | 589 | |||||||||||
Repeat Bookings | 1,234 | 1,008 | 3,406 | 2,397 | |||||||||||
Total Bookings | 1,501 | 1,267 | 4,112 | 2,986 | |||||||||||
GBV | $ | 213.7 | $ | 157.1 | $ | 580.3 | $ | 355.9 | |||||||
ABV(1) | $ | 142 | $ | 124 | $ | 141 | $ | 119 | |||||||
Total active users(2) | 718 | 602 | 1,346 | 1,012 | |||||||||||
GBV per user | $ | 298 | $ | 261 | $ | 431 | $ | 352 | |||||||
Recognized take rate(3) | 22.4 | % | 21.0 | % | 22.1 | % | 21.7 | % | |||||||
Cancellation rate(4) | 14.2 | % | 15.3 | % | 13.8 | % | 13.2 | % |
(1) ABV, or average booking value, defined as GBV ÷ Total bookings.
(2) Active user defined as unique pet owner with at least one booking in period.
(3) Recognized take rate defined as (Revenue + change in Deferred revenue) ÷ GBV.
(4) Cancellation rate defined as Cancelled bookings value ÷ GBV.
ROVER GROUP, INC.
Condensed Consolidated Statements of Operations
(in thousands, except for per share data)
(unaudited)
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||
Revenue | $ | 50,864 | $ | 35,153 | $ | 122,059 | $ | 71,831 | |||||||
Costs and expenses: | |||||||||||||||
Cost of revenue (exclusive of depreciation and amortization shown separately below) | 11,607 | 8,036 | 29,976 | 18,494 | |||||||||||
Operations and support | 7,425 | 4,199 | 19,265 | 9,916 | |||||||||||
Marketing | 8,686 | 6,403 | 27,044 | 13,532 | |||||||||||
Product development | 7,100 | 5,033 | 20,380 | 14,586 | |||||||||||
General and administrative | 30,599 | 8,899 | 53,616 | 21,266 | |||||||||||
Depreciation and amortization | 1,561 | 1,873 | 4,432 | 5,572 | |||||||||||
Total costs and expenses | 66,978 | 34,443 | 154,713 | 83,366 | |||||||||||
(Loss) income from operations | (16,114 | ) | 710 | (32,654 | ) | (11,535 | ) | ||||||||
Other income (expense), net: | |||||||||||||||
Interest income | 1,287 | 19 | 2,084 | 28 | |||||||||||
Interest expense | (19 | ) | (1,534 | ) | (61 | ) | (2,933 | ) | |||||||
Change in fair value of earnout liabilities | — | (71,318 | ) | — | (71,318 | ) | |||||||||
Change in fair value of derivative warrant liabilities | — | (12,261 | ) | 4,579 | (12,261 | ) | |||||||||
Other expense, net | (257 | ) | (116 | ) | (1,045 | ) | (194 | ) | |||||||
Total other income (expense), net | 1,011 | (85,210 | ) | 5,557 | (86,678 | ) | |||||||||
Loss before income taxes and equity method investments | (15,103 | ) | (84,500 | ) | (27,097 | ) | (98,213 | ) | |||||||
(Provision for) benefit from income taxes | (44 | ) | (36 | ) | 172 | 280 | |||||||||
Loss from equity method investments | (325 | ) | — | (325 | ) | — | |||||||||
Net loss | $ | (15,472 | ) | $ | (84,536 | ) | $ | (27,250 | ) | $ | (97,933 | ) | |||
Net loss per share attributable to common stockholders, basic and diluted | $ | (0.08 | ) | $ | (0.73 | ) | $ | (0.15 | ) | $ | (1.64 | ) | |||
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted | 182,493 | 116,597 | 181,309 | 59,825 | |||||||||||
ROVER GROUP, INC.
Condensed Consolidated Balance Sheets
(in thousands, except for per share data)
(unaudited)
September 30, 2022 | December 31, 2021 | ||||||
Assets | |||||||
Current assets | |||||||
Cash and cash equivalents | $ | 65,518 | $ | 278,904 | |||
Short-term investments | 169,137 | — | |||||
Accounts receivable, net | 49,553 | 26,023 | |||||
Prepaid expenses and other current assets | 7,937 | 6,113 | |||||
Total current assets | 292,145 | 311,040 | |||||
Property and equipment, net | 19,981 | 20,874 | |||||
Operating lease right-of-use assets | 19,396 | 21,495 | |||||
Intangible assets, net | 7,389 | 4,469 | |||||
Goodwill | 37,119 | 33,159 | |||||
Deferred tax asset, net | 1,183 | 1,477 | |||||
Long-term investments | 31,038 | 4,292 | |||||
Other noncurrent assets | 300 | 348 | |||||
Total assets | $ | 408,551 | $ | 397,154 | |||
Liabilities and Stockholders’ Equity | |||||||
Current liabilities | |||||||
Accounts payable | $ | 5,085 | $ | 5,043 | |||
Accrued compensation and related expenses | 6,469 | 6,600 | |||||
Accrued expenses and other current liabilities | 21,562 | 3,021 | |||||
Deferred revenue | 9,393 | 3,077 | |||||
Pet parent deposits | 38,844 | 28,269 | |||||
Pet care provider liabilities | 3,790 | 10,894 | |||||
Operating lease liabilities, current portion | 2,311 | 2,433 | |||||
Total current liabilities | 87,454 | 59,337 | |||||
Operating lease liabilities, net of current portion | 22,927 | 25,198 | |||||
Derivative warrant liabilities | — | 19,943 | |||||
Other noncurrent liabilities | 1,853 | 84 | |||||
Total liabilities | 112,234 | 104,562 | |||||
Commitments and contingencies (Note 11) | |||||||
Stockholders’ equity: | |||||||
Preferred stock, | — | — | |||||
Class A common stock, | 18 | 18 | |||||
Additional paid-in capital | 645,583 | 612,680 | |||||
Accumulated other comprehensive (loss) income | (1,708 | ) | 220 | ||||
Accumulated deficit | (347,576 | ) | (320,326 | ) | |||
Total stockholders’ equity | 296,317 | 292,592 | |||||
Total liabilities and stockholders’ equity | $ | 408,551 | $ | 397,154 |
ROVER GROUP, INC.
Condensed Consolidated Statements of Cash Flows
(in thousands)
(unaudited)
Nine Months Ended September 30, | |||||||
2022 | 2021 | ||||||
OPERATING ACTIVITIES | |||||||
Net loss | $ | (27,250 | ) | $ | (97,933 | ) | |
Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||||
Stock-based compensation | 14,025 | 3,142 | |||||
Depreciation and amortization | 9,634 | 10,815 | |||||
Non-cash operating lease costs | 2,065 | 1,490 | |||||
Change in fair value of earnout liabilities | — | 71,318 | |||||
Change in fair value of derivative warrant liabilities | (4,579 | ) | 12,261 | ||||
Net accretion of investment discounts | (523 | ) | — | ||||
Amortization of debt issuance costs | — | 695 | |||||
Deferred income taxes | (225 | ) | (309 | ) | |||
Loss on disposal of property and equipment | 30 | 17 | |||||
Loss from equity method investments | 325 | — | |||||
Changes in operating assets and liabilities: | |||||||
Accounts receivable | (23,480 | ) | (4,925 | ) | |||
Prepaid expenses and other current assets | (753 | ) | (3,923 | ) | |||
Other noncurrent assets | (10 | ) | (33 | ) | |||
Accounts payable | (373 | ) | 2,174 | ||||
Accrued expenses and other current liabilities | 17,799 | 2,069 | |||||
Deferred revenue and pet parent deposits | 16,807 | 21,658 | |||||
Pet care provider liabilities | (7,104 | ) | 3,603 | ||||
Operating lease liabilities | (2,358 | ) | (1,637 | ) | |||
Other noncurrent liabilities | 132 | 124 | |||||
Net cash (used in) provided by operating activities | (5,838 | ) | 20,606 | ||||
INVESTING ACTIVITIES | |||||||
Purchases of property and equipment | (443 | ) | (564 | ) | |||
Capitalization of internal-use software | (5,751 | ) | (4,602 | ) | |||
Proceeds from disposal of property and equipment | 2 | 19 | |||||
Acquisition of businesses, net of cash acquired | (5,711 | ) | — | ||||
Purchases of convertible notes | (1,310 | ) | — | ||||
Purchases of available-for-sale securities | (252,282 | ) | — | ||||
Maturities of available-for-sale securities | 55,383 | — | |||||
Net cash used in investing activities | (210,112 | ) | (5,147 | ) | |||
FINANCING ACTIVITIES | |||||||
Proceeds from exercise of stock options and issuance of common stock | 4,972 | 3,339 | |||||
Redemption of stock warrants | (7 | ) | — | ||||
Taxes paid related to settlement of equity awards | (2,224 | ) | (6,719 | ) | |||
Proceeds from reverse recapitalization and related financing | — | 268,282 | |||||
Payment of deferred transaction costs related to reverse recapitalization | — | (32,743 | ) | ||||
Repayment of borrowings on credit facilities | — | (38,124 | ) | ||||
Net cash provided by financing activities | 2,741 | 194,035 | |||||
Effect of exchange rate changes on cash and cash equivalents | (177 | ) | (15 | ) | |||
Net (decrease) increase in cash and cash equivalents | (213,386 | ) | 209,479 | ||||
Cash and cash equivalents, beginning of period | 278,904 | 80,848 | |||||
Cash and cash equivalents, end of period | $ | 65,518 | $ | 290,327 | |||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | |||||||
Cash paid for income taxes | $ | 45 | $ | 7 | |||
Cash paid for interest | 7 | 2,511 | |||||
NON-CASH INVESTING AND FINANCING ACTIVITIES | |||||||
Purchase of property and equipment in accounts payable and accrued liabilities | 138 | — | |||||
Right-of-use asset obtained in exchange for lease liabilities | 16 | 766 | |||||
Conversion of redeemable convertible preferred stock to common stock | — | 290,427 | |||||
Earnout liability recognized upon the closing of the reverse recapitalization | — | 228,082 | |||||
Derivative warrant liabilities recognized upon the closing of the reverse recapitalization | — | 22,032 | |||||
Reclassification of earnout liability to additional paid-in capital upon settlement | — | 33,010 | |||||
Reclassification of certain derivative warrant liabilities to equity upon exercise | 15,356 | — | |||||
Recognition of indemnity holdback liabilities upon acquisition of businesses | 1,563 | — | |||||
Stock-based compensation capitalized to internal-use software | 773 | — |
ROVER GROUP, INC.
Adjusted EBITDA Reconciliation
(in thousands)
(unaudited)
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||
Revenue | $ | 50,864 | $ | 35,153 | $ | 122,059 | $ | 71,831 | |||||||
Adjusted EBITDA Reconciliation: | |||||||||||||||
Net loss | $ | (15,472 | ) | $ | (84,536 | ) | $ | (27,250 | ) | $ | (97,933 | ) | |||
Add (deduct): | |||||||||||||||
Depreciation and amortization(1) | 3,309 | 3,638 | 9,634 | 10,815 | |||||||||||
Stock-based compensation expense(2) | 4,881 | 994 | 14,025 | 3,142 | |||||||||||
Interest expense | 19 | 1,534 | 61 | 2,933 | |||||||||||
Interest income | (1,287 | ) | (19 | ) | (2,084 | ) | (28 | ) | |||||||
Change in fair value, net(3) | — | 83,579 | (4,579 | ) | 83,579 | ||||||||||
Other expense, net | 257 | 116 | 1,045 | 194 | |||||||||||
Income tax expense (benefit) | 44 | 36 | (172 | ) | (280 | ) | |||||||||
Loss from equity method investments | 325 | — | 325 | — | |||||||||||
Acquisition and merger-related costs(4) | 168 | 1,280 | 658 | 2,336 | |||||||||||
Legal settlements(5) | 18,000 | — | 18,000 | — | |||||||||||
Adjusted EBITDA | $ | 10,244 | $ | 6,622 | $ | 9,663 | $ | 4,758 | |||||||
Net loss margin(6) | (30 | %) | (239 | %) | (22 | %) | (137 | %) | |||||||
Adjusted EBITDA margin(7) | 20 | % | 19 | % | 8 | % | 7 | % |
(1) Depreciation and amortization include amortization expense related to capitalized internal use software, which is recognized as cost of revenue (exclusive of depreciation and amortization shown separately) in the consolidated statement of operations.
(2) Stock-based compensation expense includes equity granted to employees as well as non-employee directors.
(3) Change in fair value, net includes the mark-to-market adjustments related to the earnout and warrant liabilities.
(4) Acquisition and merger-related costs include accounting, legal, consulting and travel-related expenses incurred in connection with the merger with Caravel and other business combinations.
(5) Legal settlements includes the amount we accrued for a binding settlement term sheet executed in October 2022.
(6) Net loss margin is net loss divided by revenue.
(7) Adjusted EBITDA margin is Adjusted EBITDA divided by revenue.
ROVER GROUP, INC.
Other Non-GAAP Financial Measures Reconciliations
(in thousands)
(unaudited)
Three Months Ended September 30, | |||||||||||||
2022 | 2021 | ||||||||||||
Amount | % | Amount | % | ||||||||||
Revenue | $ | 50,864 | 100 | % | $ | 35,153 | 100 | % | |||||
Less: Cost of revenue (exclusive of depreciation and amortization shown separately) | (11,607 | ) | (8,036 | ) | |||||||||
Adjusted to exclude the following (as related to Cost of revenue (exclusive of depreciation and amortization shown separately)): | |||||||||||||
IDS amortization | 1,749 | 1,765 | |||||||||||
Non-GAAP contribution | $ | 41,006 | $ | 28,882 | |||||||||
Non-GAAP contribution margin(1) | 81 | % | 82 | % | |||||||||
Operations and support expense | $ | 7,425 | 15 | % | $ | 4,199 | 12 | % | |||||
Less: Stock-based compensation expense | (473 | ) | (1 | %) | (43 | ) | — | % | |||||
Non-GAAP operations and support expense | $ | 6,952 | 14 | % | $ | 4,156 | 12 | % | |||||
Marketing expense | $ | 8,686 | 17 | % | $ | 6,403 | 18 | % | |||||
Less: Stock-based compensation expense | (302 | ) | (1 | %) | (71 | ) | — | % | |||||
Non-GAAP marketing expense | $ | 8,384 | 16 | % | $ | 6,332 | 18 | % | |||||
Product development expense | $ | 7,100 | 14 | % | $ | 5,033 | 14 | % | |||||
Less: Stock-based compensation expense | (1,293 | ) | (3 | %) | (287 | ) | — | % | |||||
Non-GAAP product development expense | $ | 5,807 | 11 | % | $ | 4,746 | 14 | % | |||||
General and administrative expense | $ | 30,599 | 60 | % | $ | 8,899 | 25 | % | |||||
Less: Stock-based compensation expense | (2,813 | ) | (6 | %) | (593 | ) | (1 | %) | |||||
Less: Legal settlements | (18,000 | ) | (35 | %) | — | — | % | ||||||
Non-GAAP general and administrative expense | $ | 9,786 | 19 | % | $ | 8,306 | 24 | % |
(1) Non-GAAP Contribution Margin is calculated by dividing Non-GAAP Contribution for a period by revenue for the same period.
Nine Months Ended September 30, | |||||||||||||
2022 | 2021 | ||||||||||||
Amount | % | Amount | % | ||||||||||
Revenue | $ | 122,059 | 100 | % | $ | 71,831 | 100 | % | |||||
Less: Cost of revenue (exclusive of depreciation and amortization shown separately) | (29,976 | ) | (18,494 | ) | |||||||||
Adjusted to exclude the following (as related to Cost of revenue (exclusive of depreciation and amortization shown separately)): | |||||||||||||
IDS amortization | 5,202 | 5,242 | |||||||||||
Non-GAAP Contribution | $ | 97,285 | $ | 58,579 | |||||||||
Non-GAAP Contribution margin(1) | 80 | % | 82 | % | |||||||||
Operations and support expense | $ | 19,265 | 16 | % | $ | 9,916 | 14 | % | |||||
Less: Stock-based compensation expense | (1,214 | ) | (1 | %) | (144 | ) | — | % | |||||
Non-GAAP operations and support expense | $ | 18,051 | 15 | % | $ | 9,772 | 14 | % | |||||
Marketing expense | $ | 27,044 | 22 | % | $ | 13,532 | 19 | % | |||||
Less: Stock-based compensation expense | (858 | ) | (1 | %) | (238 | ) | — | % | |||||
Non-GAAP marketing expense | $ | 26,186 | 21 | % | $ | 13,294 | 19 | % | |||||
Product development expense | $ | 20,380 | 17 | % | $ | 14,586 | 20 | % | |||||
Less: Stock-based compensation expense | (4,157 | ) | (4 | %) | (981 | ) | (1 | %) | |||||
Non-GAAP product development expense | $ | 16,223 | 13 | % | $ | 13,605 | 19 | % | |||||
General and administrative expense | $ | 53,616 | 44 | % | $ | 21,266 | 30 | % | |||||
Less: Stock-based compensation expense | (7,796 | ) | (6 | %) | (1,779 | ) | (3 | %) | |||||
Less: Legal settlements | (18,000 | ) | (15 | %) | — | — | % | ||||||
Non-GAAP general and administrative expense | $ | 27,820 | 23 | % | $ | 19,487 | 27 | % |
(1) Non-GAAP Contribution margin is calculated by dividing Non-GAAP Contribution for a period by revenue for the same period.
Contacts:
MEDIA
pr@rover.com
Kristin Sandberg
(360) 510-6365
INVESTORS
walter.ruddy@rover.com
Walter Ruddy
(206) 715-2369
FAQ
What were Rover's Q3 2022 revenue figures?
What is Rover's guidance for Q4 2022 revenue?
How much did Rover's booking value increase in Q3 2022?
What is Rover's updated full year 2022 revenue guidance?